[Isotretinoin and ulcerous colitis]

Area of Science:

• Dermatology and Gastroenterology
• Pharmacology

Background:

• Isotretinoin, a retinoid derivative, is widely prescribed for severe acne.
• The precise dermatological and systemic mechanisms of isotretinoin remain incompletely understood.
• Existing literature presents conflicting evidence regarding isotretinoin's association with inflammatory bowel disease (IBD).

Observation:

• A case is presented where a clear relationship between isotretinoin treatment and inflammatory bowel disease (IBD) was observed.
• The patient exhibited symptoms suggestive of IBD during isotretinoin therapy.

Findings:

• The study highlights a potential link between isotretinoin and the onset or exacerbation of inflammatory bowel disease (IBD).
• While hypotheses exist, the exact pathogenic mechanism connecting isotretinoin to IBD remains undetermined.

Implications:

• Clinicians should consider the potential for isotretinoin to trigger or worsen inflammatory bowel disease (IBD).
• Endoscopic evaluation is recommended for patients on isotretinoin who develop symptoms indicative of IBD.
• Further research is warranted to elucidate the relationship between isotretinoin and IBD pathogenesis.